Inhibition of S100A8/A9 Ameliorates Neuroinflammation by Blocking NET Formation Following Traumatic Brain Injury

Overview

Journal Redox Biol

Date 2025 Feb 10

PMID 39929053

Authors

Guihong Shi

Yiyao Cao

Jianye Xu

Bo Chen

Xu Zhang

Yanlin Zhu

Liang Liu

Xilei Liu

Luyuan Zhang

Yuan Zhou

Shenghui Li

Guili Yang

Xiao Liu

Fanglian Chen

Xin Chen

Jianning Zhang

Shu Zhang

Affiliations

Soon will be listed here.

Abstract

Traumatic brain injury (TBI) triggers a robust inflammatory response that is closely linked to worsened clinical outcomes. S100A8/A9, also known as calprotectin or myeloid-related protein-8/14 (MRP8/14), is an alarmin primarily secreted by activated neutrophils with potent pro-inflammatory property. In this study, we explored the roles of S100A8/A9 in modulating neuroinflammation and influencing TBI outcomes, delving into the underlying mechanisms. S100A8/A9-enriched neutrophils were present in the injured brain tissue of TBI patients, and elevated plasma levels of S100A8/A9 were correlated with poorer neurological function. Furthermore, using a TBI mouse model, we demonstrated that treatment with the selective S100A8/A9 inhibitor Paquinimod significantly mitigated neuroinflammation and neuronal death, thereby improving the prognosis of TBI mice. Mechanistically, we found that S100A8/A9, in conjunction with neutrophil activation and infiltration into the brain, enhances reactive oxygen species (ROS) production within neutrophils, accelerating PAD4-mediated neutrophil extracellular trap (NET) formation, which in turn exacerbates neuroinflammation. These findings suggest that S100A8/A9 amplifies neuroinflammatory responses by promoting NET formation in neutrophils. Inhibition of S100A8/A9 effectively attenuated NET-mediated neuroinflammation; however, when PAD4 was overexpressed in the brain using adenovirus, leading to an increased formation of NET in the brain, the anti-inflammatory effects of S100A8/A9 inhibition were markedly diminished. Further experiments with PAD4 knockout mice confirmed that the reduction of NETs could substantially alleviate S100A8/A9-driven neuroinflammation. Finally, we established that the suppression of NET formation by S100A8/A9 inhibition is primarily mediated through the AMPK/Nrf2/HO-1 signaling pathway. These findings underscore the critical pathological role of S100A8/A9 in TBI and emphasize the need for further exploration of S100A8/A9 inhibitor Paquinimod as a potential therapeutic strategy for TBI.

References

Morganti-Kossmann M, Semple B, Hellewell S, Bye N, Ziebell J . The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments. Acta Neuropathol. 2018; 137(5):731-755. DOI: 10.1007/s00401-018-1944-6. View

Liao X, Xie R, Zheng S, Fan C, Zuo M, Chen S . Bioinformatics and molecular docking reveal Cryptotanshinone as the active anti-inflammation component of Qu-Shi-Xie-Zhuo decoction by inhibiting S100A8/A9-NLRP3-IL-1β signaling. Phytomedicine. 2024; 136():156257. DOI: 10.1016/j.phymed.2024.156257. View

Zhai Y, Ye S, Wang Q, Xiong R, Fu S, Du H . Overexpressed ski efficiently promotes neurorestoration, increases neuronal regeneration, and reduces astrogliosis after traumatic brain injury. Gene Ther. 2022; 30(1-2):75-87. DOI: 10.1038/s41434-022-00320-x. View

Papayannopoulos V . Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2017; 18(2):134-147. DOI: 10.1038/nri.2017.105. View

Yan L, Bjork P, Butuc R, Gawdzik J, Earley J, Kim G . Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice. Atherosclerosis. 2013; 228(1):69-79. PMC: 3640742. DOI: 10.1016/j.atherosclerosis.2013.02.023. View

Manfredi M, Van Hoovels L, Benucci M, De Luca R, Coccia C, Bernardini P . Circulating Calprotectin (cCLP) in autoimmune diseases. Autoimmun Rev. 2023; 22(5):103295. DOI: 10.1016/j.autrev.2023.103295. View

Schauer C, Janko C, Munoz L, Zhao Y, Kienhofer D, Frey B . Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014; 20(5):511-7. DOI: 10.1038/nm.3547. View

Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q . SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther. 2021; 6(1):337. PMC: 8419672. DOI: 10.1038/s41392-021-00719-9. View

Shi M, Mi L, Li F, Li Y, Zhou Y, Chen F . Fluvoxamine Confers Neuroprotection via Inhibiting Infiltration of Peripheral Leukocytes and M1 Polarization of Microglia/Macrophages in a Mouse Model of Traumatic Brain Injury. J Neurotrauma. 2022; 39(17-18):1240-1261. DOI: 10.1089/neu.2021.0355. View

10.

Liu L, Locascio L, Dore S . Critical Role of Nrf2 in Experimental Ischemic Stroke. Front Pharmacol. 2019; 10:153. PMC: 6411824. DOI: 10.3389/fphar.2019.00153. View

11.

Zhao Z, Pan Z, Zhang S, Ma G, Zhang W, Song J . Neutrophil extracellular traps: A novel target for the treatment of stroke. Pharmacol Ther. 2022; 241:108328. DOI: 10.1016/j.pharmthera.2022.108328. View

12.

Su M, Chen C, Li S, Li M, Zeng Z, Zhang Y . Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis. Nat Cardiovasc Res. 2022; 1(8):732-747. PMC: 9362711. DOI: 10.1038/s44161-022-00108-7. View

13.

Nizamutdinov D, Shapiro L . Overview of Traumatic Brain Injury: An Immunological Context. Brain Sci. 2017; 7(1). PMC: 5297300. DOI: 10.3390/brainsci7010011. View

14.

Cutolo M, Campitiello R, Gotelli E, Soldano S . The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. Front Immunol. 2022; 13:867260. PMC: 9161083. DOI: 10.3389/fimmu.2022.867260. View

15.

Sreejit G, Abdel-Latif A, Athmanathan B, Annabathula R, Dhyani A, Noothi S . Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction. Circulation. 2020; 141(13):1080-1094. PMC: 7122461. DOI: 10.1161/CIRCULATIONAHA.119.043833. View

16.

Wang D, Zhang S, Ge X, Yin Z, Li M, Guo M . Mesenchymal stromal cell treatment attenuates repetitive mild traumatic brain injury-induced persistent cognitive deficits via suppressing ferroptosis. J Neuroinflammation. 2022; 19(1):185. PMC: 9281149. DOI: 10.1186/s12974-022-02550-7. View

17.

Liu L, Kelly M, Wierzbicki E, Escober-Nario I, Vollmer M, Dore S . Nrf2 Plays an Essential Role in Long-Term Brain Damage and Neuroprotection of Korean Red Ginseng in a Permanent Cerebral Ischemia Model. Antioxidants (Basel). 2019; 8(8). PMC: 6721128. DOI: 10.3390/antiox8080273. View

18.

Vaibhav K, Braun M, Alverson K, Khodadadi H, Kutiyanawalla A, Ward A . Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury. Sci Adv. 2020; 6(22):eaax8847. PMC: 7259928. DOI: 10.1126/sciadv.aax8847. View

19.

Dubois C, Marce D, Faivre V, Lukaszewicz A, Junot C, Fenaille F . High plasma level of S100A8/S100A9 and S100A12 at admission indicates a higher risk of death in septic shock patients. Sci Rep. 2019; 9(1):15660. PMC: 6821805. DOI: 10.1038/s41598-019-52184-8. View

20.

Kang L, Yu H, Yang X, Zhu Y, Bai X, Wang R . Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nat Commun. 2020; 11(1):2488. PMC: 7237502. DOI: 10.1038/s41467-020-16191-y. View